RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Matthew Gallagher to Comorbidity

Back to Details
This is a "connection" page, showing publications Matthew Gallagher has written about Comorbidity.
Matthew Gallagher
Connection Strength
0.238
Comorbidity
  1. Zemestani M, Ommati P, Rezaei F, Gallagher MW. Changes in neuroticism-related constructs over the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in patients on an optimal dose of SSRI. Personal Disord. 2022 03; 13(2):171-181.
    View in: PubMed
    Score: 0.161
  2. Farchione TJ, Fitzgerald HE, Curreri A, Janes AC, Gallagher MW, Sbi S, Eustis EH, Barlow DH. Efficacy of the Unified Protocol for the treatment of comorbid alcohol use and anxiety disorders: Study protocol and methods. Contemp Clin Trials. 2021 09; 108:106512.
    View in: PubMed
    Score: 0.041
  3. Paulus DJ, Gallagher MW, Raines AM, Schmidt NB, Zvolensky MJ. Intraindividual change in anxiety sensitivity and alcohol use severity 12-months following smoking cessation treatment. Behav Res Ther. 2019 05; 116:10-18.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support